Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.

The objective of this study was to examine the accuracy of the finding of a histologically well differentiated endometrial carcinoma at dilatation and curettage (D & C) prior to hysterectomy. A retrospective multicentric chart review of 137 endometrial cancer patients was conducted, including all patients in whom a well differentiated endometrial carcinoma had been diagnosed by D & C. Histopathologic grading as determined by D & C was compared with the grading established at the final histologic examination after hysterectomy. Seventy-eight percent of all cases in which a well differentiated tumor was diagnosed with D & C were confirmed as well differentiated endometrial carcinomas, whereas 20.4% had to be upgraded as moderately differentiated tumors after evaluation of the hysterectomy specimen. In one case in which a uterine adenocarcinoma was diagnosed by D & C, a well differentiated adenocarcinoma was found to be combined with a carcinosarcoma in the hysterectomy specimen. In order to avoid false findings of a well differentiated tumor, the histologic grade should be confirmed by intraoperative frozen section examination. This is especially important in cases in which surgical staging was not planned initially.

[1]  E. Trimble,et al.  Lymph node sampling and survival in endometrial cancer. , 1998, Gynecologic oncology.

[2]  H. Yun,et al.  Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. , 1998, Gynecologic oncology.

[3]  A. Ferrari,et al.  Reliability of preoperative evaluation of prognostic factors in endometrial carcinoma , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  J. Ranstam,et al.  Endometrial carcinoma: results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters. , 1997, Anticancer research.

[5]  J. Kresl,et al.  Comparison of D&C and Office Endometrial Biopsy in Predicting Final Histopathologic Grade in Endometrial Cancer , 1995, Obstetrics and gynecology.

[6]  T. Namiki,et al.  Observer variability in endometrial cytology using kappa statistics. , 1992, Journal of clinical pathology.

[7]  P. Rose,et al.  Accuracy of frozen-section diagnosis at surgery in clinical stage I and II endometrial carcinoma. , 1992, American journal of obstetrics and gynecology.

[8]  A. L. Nielsen,et al.  Evaluation of the reproducibility of the revised 1988 international federation of gynecology and obstetrics grading system of endometrial cancers with special emphasis on nuclear grading , 1991, Cancer.

[9]  M. Deppe,et al.  Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. , 1989, Gynecologic oncology.

[10]  I. Mackenzie,et al.  Discrepancy between curettage and hysterectomy histology in patients with stage l uterine malignancy , 1989, British journal of obstetrics and gynaecology.

[11]  Daniel Ag,et al.  Accuracy of office and operating room curettage in the grading of endometrial carcinoma. , 1988 .

[12]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.

[13]  D. Gal,et al.  The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma , 1992, Cancer.

[14]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .